Voya Financial

VOYA · NYSE

$95.61+$2.19 (+2.34%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $93.42

VOYA analyst rating

BuyConsensus of 15 analysts over the last 12 months. 53% rate it a buy.

Strong buy1
Buy7
Hold6
Underperform1
Sell0

12-month price target · 15 analysts

Average $106.37 (+11.3% upside)

Low: $64.02
Now: $95.61
High: $131.25

Upgrades and downgrades

The latest rating actions, newest first

VOYA analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
JP Morgan	Oct 15, 2026	Maintains	Neutral	$109.00 → $105.00	81%
Wells Fargo	Oct 12, 2026	Maintains	Equal-Weight	$104.00 → $102.00	75%
Keefe, Bruyette & Woods	Oct 9, 2026	Downgrade	Outperform → Market Perform	$110.00 → $108.00	71%
Barclays	Oct 7, 2026	Maintains	Overweight	$105.00 → $109.00	61%
Evercore ISI Group	Oct 7, 2026	Maintains	Outperform	$111.00 → $110.00	59%
UBS	Oct 6, 2026	Maintains	Buy	$125.00 → $127.00	57%
Morgan Stanley	Aug 24, 2026	Maintains	Overweight	$92.00 → $105.00	49%
Wells Fargo	Aug 19, 2026	Maintains	Equal-Weight	$100.00 → $104.00	75%
JP Morgan	Aug 11, 2026	Maintains	Neutral	$105.00 → $109.00	81%
Keefe, Bruyette & Woods	Aug 11, 2026	Maintains	Outperform	$109.00 → $110.00	71%

The case for and against

Updated Oct 21, 2026

Bull case

Voya Financial is viewed favorably because its capital-light, fee-based mix and high free cash flow conversion above 90% support strong earnings durability and robust capital generation. The 1Q26 beat of $2.26 operating EPS versus $2.00 expected, along with better-than-expected Employee Benefits results and management’s reiteration of 2%+ organic growth in Investment Management, suggests improving execution despite mixed net flows and stop-loss pressure. In addition, clean liabilities, a favorable standalone SOTP case, and credible M&A optionality support upside, with 2027E EPS raised to $12.00 from $11.25 on 2Q26 equity gains.

Bear case

Voya Financial is facing skepticism because investors continue to question execution, longer-term share performance, and whether compensation and capital allocation are aligned with market outcomes, especially after activist pressure from TCIM surfaced. Despite strong core franchises, a lower-risk fee-based mix, below-peer credit risk, and strong free cash flow supported by deferred tax assets, the stock still trades at a discount to life peers and its historical average, suggesting the market does not fully trust the sustainability of results. Near-term optimism from M&A talk and the 22% rise since TCIM was first cited may fade if operating consistency, stop-loss volatility, or other sector risks such as weaker equity markets and lower rates continue to pressure earnings and valuation.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.